We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LMNR:NASDAQLimoneira Co analysis

Data as of Oct 11, 2026 - not real-time

Latest price
$12.05
Risk: medium
7/10Medium risk

Summary

Limoneira Company trades at $12.05, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 11.1% over the past 30 days. RSI sits at 38.3, which reads as approaching oversold, and MACD momentum is bullish. Price has been bracketed by support at $11.55 and resistance at $13.49.
Multiples put this in fair territory at a P/E of 26.8. Analyst price targets sit 72.9% above the current price. Revenue is contracting at 7.7% on a -33.0% profit margin.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 45.2%, a beta of 0.22 and a maximum drawdown of 22.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.

Top market events

  • Limoneira Co LMNR posted lower Q3 revenue on lighter lemon volumes, yet raised avocado guidance and advanced a $200...
  • Limoneira NASDAQ:LMNR reported lower third-quarter fiscal 2026 revenue and a wider net loss, as lighter lemon sales...
  • Lemon pricing surged despite volume headwinds from Argentine imports.

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 13.34
  • MACD momentum is positive

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 13.34
  • Analyst targets imply +72.9% versus the current price

Long term

> 3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Negative profit margin of -33.0%
  • Analyst targets imply +72.9% versus the current price
  • Negative return on equity of -24.7%

Key metrics

Financial health

Revenue Growth-7.70%
Profit Margin-33.03%
P/E Ratio26.8
ROE-24.75%
ROA-6.63%
Debt/Equity67.61
P/B Ratio1.7
Op. Cash Flow$-14948000
Free Cash Flow$-21012376

Technical analysis

TrendBearish
RSI38.3
Support$11.55
Resistance$13.49
MA 20$12.31
MA 50$13.27
MA 200$13.34
MACDBullish
VolumeStable
Fear & Greed Index94.93

Valuation

Target Price$20.83
Upside/Downside72.89%
GradeFair
TypeBlend

Risk assessment

Beta0.22
Volatility45.15%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.